Yat Sun Or - Concepedia

Author

Yat Sun Or

Enanta Pharmaceuticals (United States)

Also Known As

Or, Yat Sun, Plemper, Richard K., Richard K. Plemper, Yat Or, Yat Sun Or

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Enanta Pharmaceuticals (United States)Abbott Fund Harvard University Medical University of South Carolina AbbVie (United States)

About

Yat Sun Or is an author at Enanta Pharmaceuticals (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	820
2	Engineering	6	6	225
3	Arts	1	1	151
4	Health Sciences	1	1	104
5	Management	1	1	151

Yat Sun Or

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Pentaprismane Philip E. Eaton, Yat Sun Or, Stephen J. Branca Journal of the American Chemical Society AltmetricsQuantitative MethodsInformationDatabasesMedia Standards	1981	151
<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450 Rakesh Tripathi, Daniel E. Cohen, I. Gaultier, Antimicrobial Agents and Chemotherapy Cytochrome P450 3A4Viral HepatitisMedicineImmunologyAntiviral Drug Development	2014	116
Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens Zhenkun Ma, Richard F. Clark, Antony Brazzale, Journal of Medicinal Chemistry Bioorganic ChemistryAntibiotic AdjuvantAntimicrobial ChemotherapyAryl Groups TetheredDrug Resistance	2001	112
Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens Yat Sun Or, Richard F. Clark, Sanyi Wang, Journal of Medicinal Chemistry Abbott ParkAntibiotic AdjuvantAntibacterial ActivityAltmetric Attention ScoreAntimicrobial Chemotherapy	2000	104
The synthesis of pentaprismane Philip E. Eaton, Yat Sun Or, Stephen J. Branca, Tetrahedron Organic ChemistrySynthesis MethodEngineeringBiomolecular Engineering	1986	90
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir Teresa I. Ng, Rakesh Tripathi, Thomas Reisch, Antimicrobial Agents and Chemotherapy	2017	87
Synthesis and Antimicrobial Activity of 4<i>H</i>-4-Oxoquinolizine Derivatives: Consequences of Structural Modification at the C-8 Position Zhenkun Ma, Daniel T. W. Chu, Curt S. Cooper, Journal of Medicinal Chemistry Bioorganic ChemistryAntibiotic AdjuvantOrganic ChemistryAntimicrobial ChemotherapyChemistry	1999	61
Studies on the synthesis of the antitumor agent CC-1065. Synthesis of the unprotected cyclopropapyrroloindole A portion using the 3,3'-bipyrrole strategy Philip Magnus, Timothy Gallagher, James Schultz, Journal of the American Chemical Society Bioorganic ChemistryAltmetric Attention ScoreUnprotected CyclopropapyrroloindolePharmacotherapyAntitumor Agent Cc-1065	1987	60
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist Derek J. Erstad, Christian T. Farrar, Sarani Ghoshal, Hepatology Communications	2018	59
Structure-function studies in a series of carboxyl-terminal octapeptide analogs of anaphylatoxin C5a Megumi Kawai, David A. Quincy, Benjamin C. Lane, Journal of Medicinal Chemistry Combinatorial ChemistryCarboxyl-terminal Octapeptide AnalogsHydrophobic Amino AcidsChemical BiologyStructure-function Studies	1992	49

Page 1